Skip to main content

Amy Rabourn

Equibles does not estimate personal net worth.

Get an email with a short summary when Opus Genetics, Inc. publishes a filing, an earnings call transcript or a press release.

Get IRD alerts

About Amy Rabourn

Amy Rabourn is recorded as Chief Accounting Officer at Opus Genetics, Inc. (IRD) since November 11, 2020. The proxy statement of Opus Genetics, Inc. reports total compensation of $789,918 for Amy Rabourn in fiscal 2023, including a base salary of $305,000. Disclosed compensation is on record for 5 fiscal years. Opus Genetics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Opus Genetics, Inc. includes Dr. George Magrath (CEO and Board Member), George Magrath (CEO and Board Member), George Magrath, M.D., M.B.A., M.S. (CEO and Board Member) and 7 others.

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Chief Accounting Officer

2020-11-11–present

Leadership on record at Opus Genetics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Opus Genetics, Inc. (IRD) $305,000 $789,918
2022 Opus Genetics, Inc. (IRD) $260,000 $499,267
2021 Opus Genetics, Inc. (IRD) $240,000 $332,093
2020 Opus Genetics, Inc. (IRD) $33,333 $266,656
2019 Opus Genetics, Inc. (IRD) — —

Recent activity

No call appearances or filed executive changes recorded yet.